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1Introduction:
In inflammatory bowel disease, as in many diseases in which an
exact etiology is still obscure, various investigators have turned to a
study of the epidemiology of the disease in hopes of finding a clue to its
cause, or to at least identify factors which exacerbate or ameliorate the
disease (1-3).

This thesis is designed to augment those studies by

investigating the possibility of a seasonal peak in the onset of the
disease cr of its relapses in children.

The much shorter lag time between

onset of svmptoms and diagnosis in children; an average of 8 months vs, 35
months (1,4), makes the former study possible.

After a retrospective chart

review involving the five year period 1974-1978 it was found that there is
no significant seasonal peak to either the first onset of symptoms of
Crohn's or ulcerative colitis or to the relapsing flares characteristic
of these diseases.

Literature Review;
Since the establishment of ulcerative colitis as a diagnostic entity
in 1375 and the description of Croon's disease in 1932 much has been
learned of the epidemiology of these diseases.

Most of this work has

been done in the past few decades and has revealed many interesting facts,
some of which may provide clues as to the etiology of inflammatory bowel
disease.

The findings of these studies are summarized below.

Incidence;
The most striking feature in the studies of these diseases is that
Crohn's disease, and perhaps also ulcerative colitis, is increasing in
incidence,

Mayberry, et al, in performing a retrospective study of the
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incidence of Crohn's disease in Cardiff, Wales found a steady rise in
incidence from 0.18 per 10^ in the 1930's shortly after the first
descriptions of Crohn's disease to 4.8 per 10^ in the 1970's (5).
Although it is true that Crohn's of the colon was not recognized until
the 1940's, and that incidence rates prior to that time might be falsely
lowered by misdiagnosis of those cases these authors point out that the
increase was spread almost equally over increasing numbers of ileocecal,
colonic, and small bowel cases and cannot be explained away by reclassification
of colonic cases.

Other studies in Britain, Scandinavia, central Europe,

Israel and South Africa have also shown an increase in the incidence of
Crohn's disease (6-1?)

(see Graph #1).

In only one of these studies was

the increase able to be accounted for by a lowered diagnostic threshold (llj.
Two other studies,

one from Northern Ireland and one from Gloucester (18,19)

found no increase in incidence, however, both of these studies were relatively
short, 7 years and 4 years respectively, and with the large amount of scatter
which can be expected in a relatively rare disease it is not surprising
that they did not see an increase comparable to that of the other,

longer

studies.
For ulcerative colitis the data available is not as clear cut.

Of

five studies three show a rising trend (8,20,21), one quite dramatically (20)
and two show essentially no change in the incidence of ulcerative colitis
over the same time period during which marked increases were occurring in
Crohn's disease (14,22) (see Graph #2),

One of the studies wnich shows an

increasing incidence involves only patients who were treated at the central
hospitals in Finland (21), and it is possible that the slight increase seen
reflects an increase in the percentage of patients refered to central
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hospitals for treatment rather than a true increase in the disease.

Of

the remaining two studies which show a rise the study from Oxford (20) is
the most dramatic and covers a defined population; however, the annual
death rates for ulcerative colitis in England and Wales fell during the
period of the study while death rates for Crohn's disease rose 2-fold (5)»
thus it is unlikely that the rising incidence found in the Oxford study
reflects any national trends.

Age Distribution}
Of particular interest to this study, whicn concerns itself with
children and adolescents, is the fact that many investigators have found
that the rise in Crohn's disease is most marked in the younger age groups,
Tresadern et al (19) found that the peak incidence of the disease was in
15"24 year olds with the most extensive disease in the younger patients,
Norlen et al (9) found that the rising incidence of the disease was due
mostly to an increase among 15~29 year olds,

Gryboski and Spiro point out

that of all patients seen at Yale-New Haven Hospital with Crohn's disease
in 1955-65, 26^ were less than 20 years old and

were less than 10,

In

the following 10 years more children with Crohn's disease were treated than
children and adults combined for the previous decade and 11% of these
children were less than 10 years old (4),

Despite such increases all

studies agree that children are at relatively low risk for Crohn's disease
with an increased risk after adolescence,

Brahme (14), Norlen (9), and

Tresadern (19) showed a single peak incidence in early adulthood with
lesser incidence thereafter.

Other studies have shown a bimodal age

distribution with peaks in the third and seventh decades (6,7,15,13).

Yet

other studies have shown essentially constant risk after the third decade

(3,5,11).

•**
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For ulcerative colitis the data is less clear.

There are suggestions

from Gjone and Mvren in Norway that ulcerative colitis is increasing
especially much among children (23)» however, the contradictions among
the epidemiologic studies noted above suggest caution in drawing conclusions
about world-wide trends.

In general the age-specific incidence of ulcerative

colitis parallels that of Crohn's disease with low incidence in childhood
and a rise thereafter (3,8,20,22).

Evans et al (20) found a bimodal

distribution with peaks in the third and seventh decades.
peaks among 15-25 year olds and JO-U-O year olds.

Gilat (22) found

A single peak was seen by

Myren et al (8) in 20-29 year olds and an even age distribution was found
by Monk et al (3) in the United States.

Sex Distribution!
Much discussion has centered around whether there is any differential
incidence between the sexes.

For Crohn's disease 7 studies found a

predominance of females (5»6,10,12-14,18), 6 found a predominance of males
(3»7**9,15»19), and 2 studies found equal numbers for both sexes (ll,20).
Where differences were found they usually did not reach statistical
significance.
For ulcerative colitis 3 studies showed a slight male predominance
(8,21,22), 2 studies showed a slight female predominance (3»20), and one
showed no difference (24).

Once again most differences were not statistically

significant.

Urban vs. Rural:
Monk et al found a predominance of inflammatory bowel disease among
city dwellers, which could be explained at least in part by the tendency
of Jews, who have a high incidence of the disease (see below), to live in

.

-5cities (3).

Kyle in Aberdeen(6) and Humphreys in Northern Ireland (l8)

also found an increased incidence of Crohn’s among urban populations
despite a lack of significant numbers of Jews in their populations.

However

these results were not confirmed by Myren and Norlen in Norway and Central
Sweden (8,9) where no such urban predominance was seen.
Studies of ulcerative colitis show an even distribution among rural
and urban populations (8,20) except for the studies from Finland which offer
contradictory evidence; the samplings from the central hospitals suggesting
a greater incidence among the rural population whereas the more comprehensive
but much shorter study involving all hospitals suggested a predominance
among urban dwellers (21,24).

Level of Educationi
Monk in Baltimore (3) also found that inflammatory bowel disease
patients had a higher average level of education than controls.

However

Kvle in Aberdeen (6) found a relative dearth of white collar workers among
Crohn's disease patients in his series and it remains to be shown if either
of these findings will be borne cut over the long run.

World Distribution:
Crohn's disease is most common in the 3ritish Isles, Sweden, Denmark
and the United States (3»5,6,9-14,18,19)S less common in Norway, Israel
and South Africa (8,15,17), and rare to the point of
where (26),

:eing reportable else¬

Firm epidemiologic data for Australia is not available.

Ulcerative colitis is generally 2-10 times more common than Croon's
disease in most studies (3,8,15,20,22), but this ratio is diminishing as
Crohn's disease becomes more common.

In one study of patients under 20
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vears old the ratio of ulcerative colitis to Croon's diminished from 1,92:1
in 1955-59 to O.J+4:1 in 1970-7^1 thus making Crohn's more common than
ulcerative colitis among the age group with whom we are most concerned in
this thesis (25).

Spatially ulcerative colitis is most common in the British

Isles, United States and Sweden and less common in Finland, Norway and
South Africa, with an intermediate rate in Israel.

One study from the

Hospital of the American University in Beirut suggests that ulcerative
colitis in Arabs is not much less common than among western countries,
although Crohn's among Arabs is vanishingly rare (26).

Ulcerative colitis

is also starting to be seen in third world countries both in Africa and in
this hemisphere (27).

Here at Yale-New Haven Hospital a boy from Brazil

was recently treated by Dr. Gryboski in the Pediatric GI Clinic for severe
ulcerative colitis,

Jews:
Jews have been shown in several studies to have up to five times the
incidence of Crohn's disease and ulcerative colitis as the non-Jewish
population (3#1^|20),

Although the validity of these results is not in

question it is interesting to note that studies from Israel have shown the
incidence of inflammatory bowel disease to be less than that found even
among non-Jews in western countries, su gesting that race is not the only
factor determining the high incidence of these disease among western Jews.

Etiologic Implications:
Given the evidence condensed above it is clear* that no single factor
will explain the observed distribution of inflammatory Dowel disease.

The

simplest etiologic hypothesis would have to include both an environmental

'
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-7a.nd a genetic component to account for what is known.

That a genetic

factor is present is amply demonstrated by the high incidence of inflammatory
bowel disease in American and European Jews despite lifestyles similar to
those of their compatriots.

It is further supported by the well-known

tendency of ulcerative colitis to run in families, and by the high incidence
of ulcerative colitis found in relatives of Crohn's disease patients (28).
Furthur support for a genetic component is found in the fact that Black &/or
Spanish-speaking Americans retain the low incidence rates of their ancestral
countries (3»29).
The evidence for an environmental component is equally compelling.
The rise in the incidence in Crohn's disease has taken place within one or
at most two generations and could not possibly be explained by genetic shifts
(28,30).

In Israel both factors are well displayed.

The lower incidence of

inflammatory bowel disease among Israeli Jews versus their American and
European counterparts can most easily be explained by their different
environments, whereas the relatively higher incidence of these diseases
among Ashkenazi versus non-Ashkenazi Jews even in Israel suggests that
genetic factors are still at work, although it is conceivable that this
could be due to different lifestyles as well.
Many theories have been advanced as to what the relevant genetic and
environmental factors might be, and these tneories have been well reviewed
by Fielding in 1970 (28), and Acheson in 1965

(31).

In brief the genetic

factor is most generally, and logically, thought to be an immunologic
susceptibility to react to a stimulus with an inflammatory bowel disease
type of picture.

The environmental stimulus is generally thought to be

either an infectious, antigenic, or dietary agent.

'
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In favor of a dietary factor Rozen et al (15) have pointed out that
Israeli Jews eat more carbohydrates and fiber and less fat and meat than
Americans, and that Ashkenazim eat more meat, eggs and milk than the nonAshkenazim who enjov a lesser incidence of inflammatory bowel disease.

In

a British study James and Gardner (32,33) have found a statistically
significant predominance of breakfast cereal eaters among Crohn's disease
patients, with corn flakes, wheat, and porridge being specifically implicated.
Milk proteins have also been thought by some to be possible etiologic
agents in inflaumatory bowel disease (3l)» and removal of milk products
from the diet ha.s been of benefit to some patients.
Another possibility is that the environmental factor is an antigenic
stimulus in the bowel to which certain people have an anomalous reaction.
This reaction could be mediated by a failure in the production of "symbodies",
antibodies which normally mask antigens and therefore provide tolerance to
certain antigenic stimuli (28).

The increasing incidence could be explained

by an increase in a bacterial or dietary antigen which in non-susceptible
populations would be entirely innocuous.
Lastly, it is possible that an infectious agent is responsible; either
bacterial, mycobacterial, or viral.

The increase in incidence of Crohn's

disease could be explained by the rise and spread of tnis infectious agent
among susceptible populations, and the heretofore low incidence of Crohn's
disease in Israel could be accounted for by tne hypotnesis that the agent
was only recently introduced into the area and is now undergoing the same
increase that it began earlier in Europe and the United States.

Mitchell

and Rees (3^) showed in 1970 that there was an agent transmissible from
Crohn's disease tissue which could elicit granuloma formation in the foot¬
pads of mice, but there has been no report since to indicate if this was
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an infectious or merely antigenic agent.

Other data which would support

an infectious etiology would be a clustering of cases, as has indeed been
found in Cardiff,

in which patients with Cronn's disease were found to

live mostly along the River Taft (2).

However, a careful search for time-

space clustering carried out in the Nottingham area failed to reveal any
positive results (35)t

and mapping of cases found in other cities as well

has failed to show any patterns (20).

Seasonal variation in the onset of

Crohn's disease or ulcerative colitis would also be evidence in favor of
an infectious etiology since such agents often show this behavior.

Cave

and Freedman (36) found statistically significant seasonal variation in
the month of onset of symptoms for Crohn's disease with peaks in January
and July.

They also found a less prominent,

but still significant, variation

for ulcerative colitis with a single peak in mid-winter.

Mayberry et al

(5) investigated seasonal variation in their patients with Crohn's disease,
using the date of diagnosis rather than date of onset of symptoms for their
study, and no seasonal variation was found.

Evans et al (20) studied

seasonal variation in the onset of symptoms in their series of ulcerative
colitis patients and found no seasonal trends.

This thesis then,

is intended

to help settle the issue of possible seasonal variation and thus clarify
the evidence for or against an infectious etiology.

Methods!
To test the null hypothesis that there is no seasonal variation in
either the onset or relapses of ulcerative colitis or Crohn’s disease a
retrospective chart review was performed involving the 5 year period from
1974 to 1978 when the review was begun.

The chart review was limited to
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only five years because the treatment of patients with inflammatory bowel
disease, at least those followed in the Pediatric Gastroenterology Clinic,
had remained fairlv uniform during that period and therefore variations in
management would not have to be taken

into account as a factor which could

influence the occurrence of relapsing flares.

Aside from treatment there

were no other variables which we felt could or need be eliminated.
Once the time period and methods for the study had been decided charts
were obtained through tne Yale-New Haven Hospital Medical Records Research
Department in one of two ways.

First all charts of patients followed for

inflammatory bowel disease in the Pediatric GI Clinic were called up by
their unit numbers which were supplied by Dr, Gryboski.

When the review

of these charts was completed additional charts were obtained by having the
research personnel call up pediatric patient charts by diagnosis for the
time period in question until all traceable cnarts had been seen.
In reviewing the charts the data which we felt would be most helpful
in determining when onset of symptoms or relapse had occurred was extracted
and condensed onto a data sheet as srown in Figure I,

Although the most

important information was of course tne symptoms directly related to the
GI tract, other signs and symptoms known to be associated with inflammatory
bowel disease were also recorded to clarify cases in which the GI symptoms
might be ambiguous.

Medications and operations were also recorded since

they have obvious effects on the course of the disease.
All available data between Jan.

197^ and Dec,

1978 was recorded with

the exception of that for patients who turned 21 during this period.
those patients data was collected only up to Dec.
turned 21.

For

of the year before they

This was done to avoid biasing the data towards the first part
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ef the year as might have happened had we included these patients up to
the moment of their 21st birthday.
Although for most patients the records were somewhat spotty with
long gaps,

sometimes of years, with no recorded visits or hospitalizations

this was not felt to be a problem since for the few patients for whom the
reason for the gaps was known it was good health that had kept them away,
and even if for some patients the gaps represent times when they were
treated elsewhere there is no reason to believe that this would bias our
data toward anv particular time of year.

Thus all patients for whom data

was available were included in the study even if the data covered only a
few months during the years we were interested in.
Once the data was collected the months of onset of symptoms or of
relapses were determined.

For the first onset of symptoms this was very

straightforward, however, for relapses this was much more complicated since
exacerbations of symptoms occurred in many contexts.

To simplify analysis

the following definitions were used to separate wnat we felt to be true
relapses of the disease from less important,

out perhaps meaningful,

increases in svmptoms.
I. True relapses- Ft. asymptomatic off steroids for 3 months or
longer before the recrudesence of GI symptoms
lasting longer than 1 week and generally
requiring that the patient be put back on
medication,
II, Intermediate flares- Pt. asymptomatic greater than 1 month
but less than 3 months off steroids before the
reappearance of symptoms,
III. Tapering flares- recurrance of symptoms as steroid dose is
tapered.
Just as for the onset of symptoms, flares were counted for the month in
which the new symptoms were first noticed by the patient, not in the month
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in which they were brought to the physicians attention and treated.
Once the frequency per month of onset of Croon's and u’C and their
flares had been determined the X2 test was applied to check for any
significant deviation from the null hypothesis.

The data for UC and Crohn's

was analyzed separately and the X2 test was applied to tne data for onset
of the disease, relapsing flares,

intermediate flares, and tapering flares

individually as well as to the comoined data for all three types of flares.
For onset of the disease, relapsing flares and intermediate flares the
frequencies were not high enough to analyze the data by individual months
since this would have given an expected frequency per month of less than
two in which case the X

2

test is invalid.

Therefore the frequencies were

collapsed down to seasons with Winter = Dec.-Feb., Spring = Mar.-Hay,
Summer = June-Aug., and Fall = Sep.-Nov. after which the expected frequencies
were all greater than two and the X

2

test could be used.

For tapering

flares and the combined data for all flares the frequencies were high
enough that the data could be analyzed by individual months so this data
p

was not collapsed into seasons.

(See Appendix 1 for details of X

test).

Results:
A total of 76 patients were found who had diagnoses of ulcerative
colitis or Crohn's disease confirmed by sigmoidoscopy, rectal biopsy, x-ray
findings or surgical pathology.
ulcerative colitis.

Of these 38 had Crohn's disease and 38 had

57 of the patients were followed by Dr. Gryooski in

the Pediatric 01 Clinic, and tne remaining 19 were followed by an assortment
of other physicians associated with Yale-New Haven Hospital,
had their first presentation within the study period,

22 patients

13 with ulcerative
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colitis and 9 wit.n Crohn's disease.

A total of 74 flares of all types

occurred among among ulcerative colitis patients during the study period,
and 74 occurred among the Crohn's patients.
coincidental).

(Similarities in numbers are

The distributions of those flares and new onsets are as

shown in Figures 2,3 & 4.
The X

2

test applied to the data for new onset, relapsing flares, and

intermediate flares by season showed no significant seasonal variation for
any of these either for Crohn's patients or ulcerative colitis patients

2
(p > 0.05).

The X

test applied to the data for tapering flares and the

combined data for all flares by month yielded similar results (p^- 0.05)
for both Crohn's and ulcerative colitis patients.

See Table 1.

Discussion:
These results, which show no seasonal variation, do not support an
infectious etiology.

However neither do they rule it out, nor do they

supnort or deny any of the other etiologic possibilities.

This particular

study is hampered by small numbers of ratients; 7/‘ patients total,

J8 each

for tJC and Crohn's, and only 22 with new onset; whereas the other studies
available had at least 200 patients in each category (36), or more (20),
and must be rea-arded as beins- much more significant than the results
presented here.

Of these two studies which looxed at month of onset, only

the one by Cave and Freedman (36) included Cronn's disease patients, and
it was among these patients that the most striking seasonal variation was
found.

The seasonal peak that they found for ulcerative colitis patients

was very small, although still statistically significant, and may not be
in such oouosition to the findings of Evans et al (20) in Oxford wnere no

Crohn’s Disease
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X

2
P

X

2
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* =0.05

New Onset

3

4.77

p > 0.05

7.81

Relapsing Flares

3

2.05

p

>0.05

7.81

Intermediate Flares

3

1.42

p >0.05

7.81

Tapering Flares

11

12.28

P> 0.05

19.67

All Flares

11

6.41

P> 0.05

19.67

X2

P

Ulcerative Colitis:
Degrees of
Freedom

X2 for

ok =0.05

New Onset

3

2.69

P

>0.05

7.81

Relapsing Flares

3

3.78

P>0.05

7.81

Intermediate Flares

3

2.99

p > 0,05

7.81

Tapering Flares

11

9.00

p > 0.05

19.67

All Flar^

11

12.58

p > 0.05

19.67
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seasonal peak was seen for ulcerative colitis.

Until the results of these

papers can be confirmed or denied by another equally large series the issue
of seasonal variation will remain an open one.
The study of the seasonal distribution of flares of ulcerative colitis
and Crohn's disease is unique to this thesis.

Acheson in 1965 (31) maintained

that flares of inflammatory bowel disease often follow upper respiratory
infections, which if true should lead to a preponderance of flares occurring
in winter and spring.

Other infections which might trigger flares could

also be expected to leave a characteristic pattern in tneir seasonal incidence.
It has also often been said, at least for ulcerative colitis, that psychological
factors play an important role in the remissions and relapses of the disease.
In the life of a child or adolescent, with each season marked by special
events and stresses; i.e.

start of school, holidays, summer vacation; a

strong psvchological factor in the initiation of flares could be expected
to lead to a seasonal variation in their occurrence.

Other envirnmental

factors may lead to a seasonal variability as well, as demonstrated by the
autumn trough and winter peak in the incidence of perforated ulcers following
the holiday excesses (36).
that

l)

That no such variation was found can mean either

intercurrent infections, seasonal changes in diet, or psychological

stresses have no effect upon flares of inflammatory bowel disease, or

2) the

numbers of patients and patient flares which we were aole to collect are
insufficient to show a seasonal variation which may have become obvious
were greater numbers available.

It is also possible that many factors play

a role in the initiation of flares, and that some or many of them may have
led to a seasonal peak if operating alone, but that together their peaks
and troughs overlap to produce a nearly constant incidence.

Such speculations

must await a more difinitive study involving much greater numbers of patients
than were available at Yale-New Haven Hospital alone.

Chi-squared (X2) test:

observed ” ^expected)*"/ ^expected

Where n = number of time periods
f = frequency

X

values for various values of p can be found in statistical tables.
X2 for p = 0.05 is 7.81
X2 for p = 0.05 is 19.67

df = 3
df = 11

Where p = probability of the observed variation arising by chance
df = degrees of freedom = n-1
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